$NGTF down 15% after today's Pr. Likely this

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
152
$NGTF down 15% after today's Pr.

Likely this part:
Profitability Projected for 2019 Q4
< >

Nightfood Investor Call Recap: National Roll-out on Track, Profitability Projected for 2019 Q4, Dairy-Free and CBD Ice Cream in the Works
7:37 am ET May 29, 2019 (Globe Newswire) Print

via NEWMEDIAWIRE -- Nightfood, Inc. (OTCQB: NGTF), the innovative ice cream company solving America's $50 billion-dollar nighttime snacking problem, conducted a quarterly investor conference call yesterday, May 28, 2019.

On the call, Nightfood CEO Sean Folkson answered questions from Company shareholders and other interested parties.

Investor questions covered topics including initial sales velocity and the national rollout of Nightfood ice cream, the Nightfood influencer program, growth financing, the ice cream competitive landscape, company profitability targets, the research & development pipeline, and MJ Munchies and the Half-Baked brand of cannabis edibles.

When asked about distribution targets, Folkson commented "We are very much on track for our distribution goals. In fact, we project month over month revenue growth that will have us doing our first million dollar quarter this year, and also, I believe, our first three million dollar quarter this year, 2019."

It was also revealed on the call that Management projects reaching profitability in the second half of 2019.

Folkson revealed that the Company is exploring CBD ice cream products, as well as adding additional flavors of the current Nightfood ice cream line, and plant-based non-dairy frozen dessert options. The timeline for release of any CBD products will depend on FDA regulation, but the additional flavors and non-dairy options are expected to be available later this year.

Responding to a question about Nightfood's financing strategy, Folkson alluded to the possibility of an uplist to a major exchange such as the NASDAQ or the NYSE in conjunction with an equity capital raise. He stated, "Since an uplist is certainly in play if we execute over the next couple of quarters, the kind of equity cash infusion that comes with an uplist, that can also provide us, along with cash flow, with all the capital we need to successfully continue the national rollout."

Within four months of manufacture of the first pint of Nightfood ice cream, the product was available in three of the top-50 supermarket chains in the United States. Management has publicly stated their goal to have secured distribution for Nightfood in 10,000 points of distribution by March 31, 2020.

A replay of the Nightfood Holdings May 28, 2019 Investor Call is now available at SmallCapVoice.com

About Nightfood Holdings:

Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.

On Feb 8, 2019, it was announced that Nightfood ice cream won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers.

With the overwhelming majority of at-home ice cream consumption occurring in the hours before bed, Nightfood's sleep-friendly nighttime ice cream, formulated by sleep and nutrition experts, delivers benefits found in no other product on the market.

Market research giant Mintel identified nighttime specific food and beverages as one of their most "compelling and category changing" trends for the coming years

Nightfood ice cream is rolling out nationally and has recently announced distribution in the popular Meijer supermarket chain throughout the Midwest, with concentration in the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus, and Milwaukee, as well as Lowes Foods, with 78 stores in the Carolinas and Virginia.

To enter the Nightfood(R) Ice Cream Giveaway, where the Company is giving away a one-year supply of Nightfood ice cream, plus a brand-new freezer to store it in, visit http://nightfood.com

MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the brand name "Half-Baked", for which they've successfully secured trademark rights.

nightfood-product-page-header-family-shot-1.png
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 7

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Space-ng's New Computer Vision Solutions

Updated Category News Views 125

Introducing Space-ng's Innovative Vision System Space-ng is excited to present a revolutionary Hardware Development Kit (HDK) and a Software Development Kit (SDK) tailored for their renowned Sol3 Vision System. This initiative embodies a commitment to affordable, rugged, and air-cooled technology suitable for space applications. The HDK is designed for rapid prototyping,...

Continue Reading
iOnctura Advances Treatment Options for Uveal Melanoma Patients

Updated Category News Views 182

iOnctura Reports Significant Clinical Progress in Uveal Melanoma iOnctura, a clinical-stage biopharmaceutical company, has recently unveiled critical advancements in its efforts to combat uveal melanoma, a rare form of eye cancer that often presents significant treatment challenges. The company has completed its Phase I DIONE-01 study, showcasing encouraging clinical...

Continue Reading
Spyre Therapeutics Progresses with SPY001 for IBD Treatment

Updated Category News Views 115

Spyre Therapeutics Reports Encouraging Phase 1 Trial Data Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently released promising interim results from its Phase 1 trial of SPY001, an innovative half-life extended monoclonal antibody aimed at treating inflammatory bowel disease (IBD). The study indicates that SPY001 was well...

Continue Reading
Understanding the University of Phoenix Tuition Guarantee

Updated Category News Views 194

Understanding the University of Phoenix Tuition Guarantee Fixed tuition and new transparency initiatives support adult learners in planning educational expenses. University of Phoenix is enhancing its commitment to clear and consistent tuition costs through its Tuition Guarantee initiative. This program ensures that students benefit from a locked-in tuition rate from the...

Continue Reading
Halper Sadeh Investigates Shareholder Rights for IPXX, PWUP, DECA, TTNP

Updated Category News Views 38

Halper Sadeh LLC Investigates Shareholder Rights Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently examining several companies for potential violations of federal securities laws and breaches of fiduciary duties. This investigation focuses on significant firms involved in mergers, with the aim of safeguarding shareholder interests....

Continue Reading